Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Apr;50 Suppl(Suppl):S237-42.
doi: 10.1194/jlr.R800033-JLR200. Epub 2008 Nov 14.

Phospholipase A2 structure/function, mechanism, and signaling

Affiliations
Review

Phospholipase A2 structure/function, mechanism, and signaling

John E Burke et al. J Lipid Res. 2009 Apr.

Abstract

Tremendous advances in understanding the structure and function of the superfamily of phospholipase A2 (PLA2) enzymes has occurred in the twenty-first century. The superfamily includes 15 groups comprising four main types including the secreted sPLA2, cytosolic cPLA2, calcium-independent iPLA2, and platelet activating factor (PAF) acetyl hydrolase/oxidized lipid lipoprotein associated (Lp)PLA2. We review herein our current understanding of the structure and interaction with substrate phospholipids, which resides in membranes for a representative of each of these main types of PLA2. We will also briefly review the development of inhibitors of these enzymes and their roles in lipid signaling.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
A: The group IA phospholipase A2 (PLA2) with phospholipid substrate modeled in the active site. The active site residues His-48 and Asp-93 and the bound Ca2+ is shown in purple. Ca2+ is bound by Asp-49 as well as the carbonyl oxygens of Tyr-28, Gly-30, and Gly-32. Aromatic residues are shown in white. Adapted from Dennis (9). B: Model of the lipid surface binding of the group IA PLA2 is shown with residues on the interfacial binding surface Tyr-3, Trp-19, Trp 61, and Phe 64 shown in stick form. Adapted from Burke et al. (20).
Fig. 2.
Fig. 2.
A: Group IVA PLA2 crystal structure as determined by Dessen et al. (33). The C2 domain is shown in orange, with two bound Ca2+ ions shown in purple. The catalytic domain is shown on the right with the cap region colored yellow, and the lid region 415–432 colored magenta. The active site residues Ser-228, Asp-549, and Arg-200 are shown in stick form colored red. The PIP2 binding site is shown in dark blue, and the C1P binding site is shown in cyan. B: Model of the lipid-binding surface of the group IVA (GIVA) PLA2 with residues colored based on interaction with lipid membrane. Adapted from Burke et al (35).

References

    1. Funk C. D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 294 1871–1875. - PubMed
    1. Rivera R., and J. Chun. 2008. Biological effects of lysophospholipids. Rev. Physiol. Biochem. Pharmacol. 160 25–46. - PubMed
    1. Stephens W. W., J. L. Walker, and W. Myers. 1898. The action of cobra poison on the blood: a contribution to the study of passive immunity. J. Pathol. Bacteriol. 5 279–301.
    1. Seilhamer J. J., W. Pruzanski, P. Vadas, S. Plant, J. A. Miller, J. Kloss, and L. K. Johnson. 1989. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J. Biol. Chem. 264 5335–5338. - PubMed
    1. Kramer R. M., C. Hession, B. Johansen, G. Hayes, P. McGray, E. P. Chow, R. Tizard, and R. B. Pepinsky. 1989. Structure and properties of a human non-pancreatic phospholipase A2. J. Biol. Chem. 264 5768–5775. - PubMed

Publication types

Substances